EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Novel chemokine biomarkers in melanoma †

Alessio Giubellino iD, Sara E Hamilton iD

The Journal of Pathology · 2024

DOI: 10.1002/path.6323 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Alessio Giubellino and 1 co-authors. Institution: Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. Major MEDLINE topics: Biomarkers, Tumor, Chemokines, Melanoma, Skin Neoplasms. Cited 1 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

The melanoma tumor microenvironment is a complex milieu of cancer, inflammatory, and stromal cells. In this context, chemokines play a pivotal role in recruiting inflammatory cells and influence the tumor, exerting both pro‐tumorigenic and anti‐tumoral roles. Interactions between these cells is what ultimately hold together and transform the tumor into an efficient machine. A recent study found that chemokines CCL8, CCL15, and CCL20 were upregulated in melanoma cells when co‐cultured with macrophages and were associated with poor survival rates. CCL8 and CCL15 also stimulated melanoma cell growth, invasion, and metastasis, and were highly expressed in tumors prone to metastasize, suggesting these chemokines are attractive and independent biomarkers. Understanding the intricated interactions within the tumor microenvironment could lead to prognostic biomarkers and to the development of new therapeutic strategies for melanoma. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Biomarkers, TumorChemokinesMelanomaSkin NeoplasmsHumansPrognosisTumor Microenvironment

Author keywords

CCL15CCL20CCL8chemokinesmelanomatumor‐associated macrophages

Substances

Biomarkers, TumorChemokines

Authors and institutions

  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Center for Immunology, University of Minnesota, Minneapolis, MN, USA.

ORCID profiles: Alessio Giubellino, Sara E Hamilton

Cite

APA

Giubellino, A., & Hamilton, S. E. (2024). Novel chemokine biomarkers in melanoma †. The Journal of Pathology. https://doi.org/10.1002/path.6323

Vancouver

Giubellino A, Hamilton SE. Novel chemokine biomarkers in melanoma †. The Journal of Pathology. 2024. doi:10.1002/path.6323

BibTeX
@article{Giubellino2024,
  author = {Giubellino, Alessio and Hamilton, Sara E},
  title = {Novel chemokine biomarkers in melanoma †},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6323}
}
Start for free →